[Therapeutic effect of hetacillin in dysentery patients and carriers].
D000293:Adolescent; D000328:Adult; D002353:Carrier State / Q000188:drug therapy*; D002648:Child; D002701:Chloramphenicol / Q000494:pharmacology; D004405:Dysentery, Bacillary / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D010403:Penicillin Resistance; D010406:Penicillins / Q000009:adverse effects / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use*; D012762:Shigella dysenteriae / Q000187:drug effects; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology
D010406:Penicillins; D007612:Kanamycin; D002701:Chloramphenicol; D013752:Tetracycline; D013307:Streptomycin